Article Text

Download PDFPDF
CASE REPORT
Bilateral primary adrenal lymphoma successfully treated with non-CHOP chemotherapy regimen
  1. Anshul Singh1,
  2. Karthik Udupa2,
  3. Sharath P Madhyastha3,
  4. Swati Sharma4
  1. 1Internal Medicine, Manipal University Kasturba Medical College Manipal, Manipal, Karnataka, India
  2. 2Medical Oncology, Kasturba Medical College, Manipal university, Manipal, Karnataka, India
  3. 3Internal Medicine, Kasturba Medical College Manipal, Manipal, Karnataka, India
  4. 4Pathology, Kasturba Medical College, Manipal, Karnataka, India
  1. Correspondence to Dr Anshul Singh, Anshul.singhp{at}gmail.com

Summary

Primary bilateral non-Hodgkin’s lymphoma of the adrenal gland is a rare presentation with <200 reported cases. We report a 70-year-old man who presented with vomiting and abdominal pain for 2 weeks and was subsequently diagnosed to have high-grade lymphoma of the adrenal glands. The patient was then started on a rituximab–bendamustine chemotherapy regimen. The patient tolerated treatment well without significant side effects. Repeat positron emission tomography CT scan after four cycles of chemotherapy showed complete response. The patient has completed six cycles of chemotherapy and is on regular follow-up with no signs of relapse.

  • oncology
  • malignant and benign haematology

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors AS: collecting information related to case report and preparing case report. KU: drafting the case report, assisted in the production of the report and was also involved in the care of the patient. SPM: revising it critically for important intellectual content. SS: providing histopathological slides. All authors read and approved the final manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.